Duration of Protection: GSK DTaP Vaccines

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
DiphtheriaAcellular PertussisTetanus
Interventions
BIOLOGICAL

Infanrix

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Indicated as a 5-dose series in infants and children 6 weeks to 7 years of age.

BIOLOGICAL

Pediarix

Diphtheria and Tetanus Toxoids and Acellular Pertussis Ad-sorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Indicated as a 3-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).

BIOLOGICAL

Kinrix

Diphtheria and Tetanus Toxoids and Acellular Pertussis Ad-sorbed and Inactivated Poliovirus Vaccine

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02447978 - Duration of Protection: GSK DTaP Vaccines | Biotech Hunter | Biotech Hunter